[Turner syndrome].
Katsumata
Noriyuki
N
Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development.
D041321:Chromosomes, Human, X / Q000235:genetics; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D017353:Gene Deletion; D018398:Homeodomain Proteins / Q000235:genetics; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008525:Medroxyprogesterone / Q000008:administration & dosage; D011379:Prognosis; D011994:Recombinant Proteins / Q000627:therapeutic use; D000074122:Short Stature Homeobox Protein; D013197:Stanozolol / Q000627:therapeutic use; D014157:Transcription Factors / Q000235:genetics; D014424:Turner Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy
D004967:Estrogens; D018398:Homeodomain Proteins; D011994:Recombinant Proteins; C106071:SHOX protein, human; D000074122:Short Stature Homeobox Protein; D014157:Transcription Factors; D019382:Human Growth Hormone; D013197:Stanozolol; D008525:Medroxyprogesterone